Children who achieved remission vs. desensitization alone after stopping peanut oral immunotherapy had a larger improvement in health-related quality of life at 3 years since treatment completion, according to data published in Allergy.Additionally, fewer patients in the remission group had reactions to peanut at the 3-year mark, according to researchers.